Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -302,282 | -170,684 | -606,639 | -483,449 | -323,800 |
| Depreciation Amortization | 11,004 | 5,089 | 13,164 | 8,894 | 4,384 |
| Income taxes - deferred | N/A | N/A | -1,619 | N/A | N/A |
| Accounts receivable | -22,750 | -24,908 | -22,778 | -23,790 | -17,586 |
| Other Working Capital | -39,661 | -56,019 | -13,482 | -28,405 | -31,205 |
| Other Operating Activity | 85,999 | 55,795 | 156,548 | 135,848 | 95,179 |
| Operating Cash Flow | $-267,690 | $-190,727 | $-474,806 | $-390,902 | $-273,028 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 171,803 | 109,711 | 219,815 | 324,961 | 241,916 |
| PPE Investments | -5,220 | -3,211 | -44,267 | -42,667 | -38,972 |
| Sale Of Investment | 3,022 | N/A | N/A | N/A | 14,627 |
| Purchase Sale Intangibles | -12,500 | -10,000 | -2,500 | -2,500 | -2,500 |
| Other Investing Activity | -14,606 | -12,065 | -7,548 | -7,277 | -6,849 |
| Investing Cash Flow | $154,999 | $94,435 | $168,000 | $275,017 | $210,722 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 384,881 | -58 | 388,170 | 57,560 | 32,326 |
| Other Financing Activity | 0 | 0 | -28 | -28 | -28 |
| Financing Cash Flow | $384,881 | $-58 | $388,142 | $57,532 | $32,298 |
| Exchange Rate Effect | -1,327 | -679 | 462 | -641 | 75 |
| Beginning Cash Position | 219,399 | 219,399 | 137,601 | 137,601 | 137,601 |
| End Cash Position | 490,262 | 122,370 | 219,399 | 78,607 | 107,668 |
| Net Cash Flow | $270,863 | $-97,029 | $81,798 | $-58,994 | $-29,933 |
| Free Cash Flow | |||||
| Operating Cash Flow | -267,690 | -190,727 | -474,806 | -390,902 | -273,028 |
| Capital Expenditure | -5,220 | -3,211 | -44,267 | -42,667 | -38,972 |
| Free Cash Flow | -272,910 | -193,938 | -519,073 | -433,569 | -312,000 |